| 翻訳と辞書 |
Amgen
AMGen (formerly Applied Molecular Genetics) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, AMGen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
== History ==
The word AMGen is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its initial public offering). The company's first chief executive officer, from 1980, was co-founder George B. Rathmann, followed by Gordon M. Binder in 1988,〔(【引用サイトリンク】title=Amgen, Form 10-K, Annual Report, Filing Date Mar 24, 1998 )〕 followed by Kevin W. Sharer in 2000.〔(【引用サイトリンク】title=Amgen, Form 10-K405, Filing Date Mar 7, 2000 )〕 Robert A. Bradway became Amgen’s president and chief executive officer in May 2012 following Sharer's retirement.〔(【引用サイトリンク】title=Amgen, Form 8-K, Current Report, Filing Date May 24, 2012 )〕
The company has made at least five major corporate acquisitions.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Amgen」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|